Physician profile
Eileen E Watrous
NPI 1730237512
$1,766.38
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $167 · 2021: $644 · 2022: $368 · 2023: $257 · 2024: $29.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $517.35 | 2019-2023 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Novo Nordisk INC | $196.24 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.02 | 2021-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $152.64 | 2019-2021 | |
| Mannkind Corporation | $123.79 | 2019-2021 | |
| Lilly USA, LLC | $114.53 | 2019-2023 | Jardiance |
| Glaxosmithkline, LLC. | $76.83 | 2021-2023 | Shingrix, Arexvy |
| Dynavax Technologies Corporation | $58.42 | 2022 | |
| Exact Sciences Corporation | $44.75 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $37.93 | 2022 | |
| Abbvie INC. | $32.79 | 2023 | Qulipta |
| Zealand Pharma US, INC. | $32.13 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $30.67 | 2019 | |
| Shire North American Group INC | $24.32 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $22.96 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.65 | 2019 | |
| Abbott Laboratories | $20.71 | 2021 | |
| Hologic Sales and Service, LLC | $18.79 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.66 | 2022 | |
| Ibsa Pharma INC. | $15.74 | 2020 | |
| Pfizer INC. | $14.42 | 2023 | |
| Circassia INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Watrous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.